CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 151 filers reported holding CHEMOCENTRYX INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $140,286,000 | +39.9% | 2,715,554 | -32.9% | 0.01% | +50.0% |
| Q2 2022 | $100,259,000 | +9.8% | 4,045,964 | +11.1% | 0.01% | +20.0% |
| Q1 2022 | $91,296,000 | -6.0% | 3,641,663 | +36.6% | 0.01% | 0.0% |
| Q4 2021 | $97,077,000 | +24.1% | 2,666,207 | -41.7% | 0.01% | +25.0% |
| Q3 2021 | $78,220,000 | +23.7% | 4,574,262 | -3.2% | 0.00% | +33.3% |
| Q2 2021 | $63,249,000 | -31.7% | 4,723,626 | +161.5% | 0.00% | -40.0% |
| Q1 2021 | $92,558,000 | -25.7% | 1,806,368 | -10.3% | 0.01% | -37.5% |
| Q4 2020 | $124,630,000 | +15.5% | 2,012,764 | +2.2% | 0.01% | +14.3% |
| Q3 2020 | $107,914,000 | +9.1% | 1,969,235 | +14.5% | 0.01% | 0.0% |
| Q2 2020 | $98,948,000 | +128.8% | 1,719,631 | +59.8% | 0.01% | +75.0% |
| Q1 2020 | $43,242,000 | +4.1% | 1,076,196 | +2.4% | 0.00% | +33.3% |
| Q4 2019 | $41,552,000 | +711.2% | 1,050,619 | +39.1% | 0.00% | – |
| Q3 2019 | $5,122,000 | -69.4% | 755,448 | -58.0% | 0.00% | -100.0% |
| Q2 2019 | $16,736,000 | +163.4% | 1,799,564 | +293.3% | 0.00% | – |
| Q1 2019 | $6,355,000 | +19.5% | 457,546 | -6.1% | 0.00% | – |
| Q4 2018 | $5,317,000 | -15.0% | 487,355 | -1.5% | 0.00% | – |
| Q3 2018 | $6,255,000 | +6.8% | 494,984 | +11.3% | 0.00% | – |
| Q2 2018 | $5,856,000 | +1.3% | 444,550 | +4.6% | 0.00% | – |
| Q1 2018 | $5,779,000 | +118.9% | 424,832 | -4.2% | 0.00% | – |
| Q4 2017 | $2,640,000 | -16.9% | 443,300 | +3.6% | 0.00% | – |
| Q3 2017 | $3,178,000 | -20.9% | 428,004 | -0.3% | 0.00% | – |
| Q2 2017 | $4,016,000 | +37.6% | 429,088 | +7.0% | 0.00% | – |
| Q1 2017 | $2,919,000 | -2.1% | 401,192 | -0.4% | 0.00% | – |
| Q4 2016 | $2,981,000 | +18.0% | 402,792 | -3.7% | 0.00% | – |
| Q3 2016 | $2,526,000 | +38.2% | 418,119 | +2.7% | 0.00% | – |
| Q2 2016 | $1,828,000 | +77.3% | 407,178 | -1.8% | 0.00% | – |
| Q1 2016 | $1,031,000 | -69.1% | 414,741 | +0.5% | 0.00% | – |
| Q4 2015 | $3,341,000 | +34.0% | 412,727 | +0.2% | 0.00% | – |
| Q3 2015 | $2,493,000 | -27.7% | 411,827 | -1.8% | 0.00% | – |
| Q2 2015 | $3,449,000 | +21.3% | 419,261 | +11.2% | 0.00% | – |
| Q1 2015 | $2,843,000 | +10.8% | 376,966 | +0.4% | 0.00% | – |
| Q4 2014 | $2,565,000 | +62.4% | 375,622 | +7.1% | 0.00% | – |
| Q3 2014 | $1,579,000 | -23.1% | 350,785 | -0.1% | 0.00% | – |
| Q2 2014 | $2,053,000 | -12.6% | 351,113 | -0.8% | 0.00% | – |
| Q1 2014 | $2,349,000 | -15.0% | 353,767 | -13.5% | 0.00% | – |
| Q4 2013 | $2,764,000 | +50.1% | 408,944 | +23.4% | 0.00% | – |
| Q3 2013 | $1,842,000 | -58.5% | 331,278 | +5.6% | 0.00% | -100.0% |
| Q2 2013 | $4,439,000 | – | 313,833 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |